Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,512.38 -3.89 -0.03%
TOPIX 1,171.40 -1.97 -0.17%
HANG SENG 22,760.24 64.23 0.28%

Perrigo Company Announces Quarterly Dividend



                 Perrigo Company Announces Quarterly Dividend

PR Newswire

ALLEGAN, Mich., May 2, 2013

ALLEGAN, Mich., May 2, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq:
PRGO;TASE) today announced that its Board of Directors declared a quarterly
dividend of $0.09 per share, payable on June 18, 2013 to shareholders of
record on May 31, 2013.

(Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO )

From its beginnings as a packager of generic home remedies in 1887, Allegan,
Michigan-based Perrigo Company has grown to become a leading global provider
of quality, affordable healthcare products. Perrigo develops, manufactures and
distributes over-the-counter (OTC) and generic prescription (Rx)
pharmaceuticals, infant formulas, nutritional products, pet health, dietary
supplements and active pharmaceutical ingredients (API). The Company is the
world's largest manufacturer of OTC pharmaceutical products for the store
brand market. The Company's primary markets and locations of logistics
operations have evolved over the years to include the United States, Israel,
Mexico, the United Kingdom, India, China and Australia. Visit Perrigo on the
Internet (http://www.perrigo.com).

SOURCE Perrigo

Website: http://www.perrigo.com
Contact: Arthur J. Shannon, Vice President, Investor Relations and
Communication, (269) 686-1709, ajshannon@perrigo.com, or Bradley Joseph,
Senior Manager, Investor Relations and Communication, (269) 686-3373,
bradley.joseph@perrigo.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement